GLPwatch

Exploring the antioxidant properties of semaglutide: A comprehensive review.

J Diabetes Complications · 2024

Last updated 2026-05-28

Semaglutide is a GLP-1 drug used to treat diabetes that may also help reduce oxidative stress, a harmful process linked to diabetes complications. Studies suggest it has antioxidant effects, but researchers are still investigating how it works and how strong these effects are.

AI summary of the abstract below.

JournalJ Diabetes Complications, 2024
Citations7
Relative citation ratio1.86
NIH percentile71
Molecules semaglutide

Abstract

Patients with diabetes commonly experience an aberrant production of free radicals and weakened antioxidative defenses, making them highly susceptible to oxidative stress development. This, in turn, can induce and promote diabetic complications. Therefore, utilizing antidiabetic agents with antioxidative properties can offer dual benefits by addressing hyperglycemia and reducing oxidative damage. Semaglutide, a recently approved oral form of glucagon-like peptide-1 (GLP-1) analogues, has shown potent antidiabetic effects. Additionally, recent studies have suggested that it possesses antioxidative properties. However, the exact effects and the molecular pathways involved are not well understood. In this review, we present the latest findings on the antioxidative impacts of semaglutide and draw conclusions about the mechanisms involved.

Verbatim abstract via PubMed 39549371 ↗

Related research